CHINA PHARMA HOLDINGS, INC. Comprehensive Income
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Comprehensive Income of -$842.91 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$842.91K.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$709.56K.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.04M.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$594.15K.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$2.92M.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$4.87M.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$3.20M.
- CHINA PHARMA HOLDINGS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$4.96M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$842.91K 10-Q · filed 2026-08-14 | -$1.55M 10-Q · filed 2026-08-14 | -$2.60M derived: sum of 3 quarters · filed 2026-08-14 | -$3.19M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$709.56K 10-Q · filed 2026-05-15 | -$1.75M derived: sum of 2 quarters · filed 2026-05-15 | -$2.35M derived: sum of 3 quarters · filed 2026-05-15 | -$2.86M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$1.64M derived: sum of 2 quarters · filed 2026-04-01 | -$2.15M derived: sum of 3 quarters · filed 2026-08-14 | -$2.92M 10-K · filed 2026-04-01 | |||
| 2025-09-30 | -$594.15K 10-Q · filed 2025-11-12 | -$1.10M derived: sum of 2 quarters · filed 2026-08-14 | -$1.88M 10-Q · filed 2025-11-12 | -$3.31M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$508.10K 10-Q · filed 2026-08-14 | -$1.29M 10-Q · filed 2026-08-14 | -$2.71M derived: sum of 3 quarters · filed 2026-08-14 | -$3.69M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$778.06K 10-Q · filed 2026-05-15 | -$2.21M derived: sum of 2 quarters · filed 2026-05-15 | -$3.19M derived: sum of 3 quarters · filed 2026-05-15 | -$4.67M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$2.41M derived: sum of 2 quarters · filed 2026-04-01 | -$3.89M derived: sum of 3 quarters · filed 2026-04-01 | -$4.87M 10-K · filed 2026-04-01 | |||
| 2024-09-30 | -$980.27K 10-Q · filed 2025-11-12 | -$2.46M derived: sum of 2 quarters · filed 2025-11-12 | -$3.44M 10-Q · filed 2025-11-12 | -$4.55M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$1.48M 10-Q · filed 2025-08-14 | -$2.46M 10-Q · filed 2025-08-14 | -$3.57M derived: sum of 3 quarters · filed 2025-08-14 | -$4.27M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$977.47K 10-Q · filed 2025-05-14 | -$2.08M derived: sum of 2 quarters · filed 2025-05-14 | -$2.79M derived: sum of 3 quarters · filed 2025-05-14 | -$3.91M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.81M derived: sum of 2 quarters · filed 2025-03-31 | -$2.93M derived: sum of 3 quarters · filed 2025-03-31 | -$3.20M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$706.20K 10-Q · filed 2024-11-13 | -$777.61K 10-Q · filed 2023-11-13 | -$1.82M derived: sum of 2 quarters · filed 2024-11-13 | -$2.09M 10-Q · filed 2024-11-13 | -$3.17M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$1.12M 10-Q · filed 2024-08-14 | -$1.39M 10-Q · filed 2024-08-14 | -$2.47M derived: sum of 3 quarters · filed 2024-08-14 | -$3.86M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$270.65K 10-Q · filed 2023-05-12 | -$1.35M derived: sum of 2 quarters · filed 2024-04-01 | -$2.74M derived: sum of 3 quarters · filed 2024-04-01 | -$4.26M derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$2.47M derived: sum of 2 quarters · filed 2024-04-01 | -$3.99M derived: sum of 3 quarters · filed 2024-04-01 | -$4.96M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$1.39M 10-Q · filed 2023-11-13 | -$2.91M derived: sum of 2 quarters · filed 2023-11-13 | -$3.88M 10-Q · filed 2023-11-13 | -$4.72M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$1.52M 10-Q · filed 2023-08-14 | -$2.49M 10-Q · filed 2023-08-14 | -$3.33M derived: sum of 3 quarters · filed 2023-08-14 | -$4.19M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$977.84K 10-Q · filed 2023-05-12 | -$1.81M derived: sum of 2 quarters · filed 2023-05-12 | -$2.68M derived: sum of 3 quarters · filed 2023-05-12 | -$3.32M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -$836.97K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.70M derived: sum of 2 quarters · filed 2023-03-30 | -$2.34M derived: sum of 3 quarters · filed 2023-03-30 | -$3.18M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$864.17K 10-Q · filed 2022-11-14 | -$1.51M derived: sum of 2 quarters · filed 2022-11-14 | -$2.34M 10-Q · filed 2022-11-14 | -$3.06M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$641.31K 10-Q · filed 2022-08-11 | -$1.48M 10-Q · filed 2022-08-11 | -$2.20M derived: sum of 3 quarters · filed 2022-08-11 | -$2.74M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$838.65K 10-Q · filed 2022-05-12 | -$1.56M derived: sum of 2 quarters · filed 2022-05-12 | -$2.10M derived: sum of 3 quarters · filed 2022-05-12 | -$2.08M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$719.02K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$1.26M derived: sum of 2 quarters · filed 2022-03-30 | -$1.24M derived: sum of 3 quarters · filed 2022-03-30 | -$2.10M 10-K · filed 2022-03-30 | |||
| 2020-09-30 | -$539.45K 10-Q · filed 2021-11-12 | -$520.60K derived: sum of 2 quarters · filed 2021-11-12 | -$1.38M 10-Q · filed 2021-11-12 | -$18.98M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $18.85K 10-Q · filed 2021-08-13 | -$839.08K 10-Q · filed 2021-08-13 | -$18.44M derived: sum of 3 quarters · filed 2021-08-13 | -$20.05M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$857.93K 10-Q · filed 2021-05-14 | -$18.46M derived: sum of 2 quarters · filed 2021-05-14 | -$20.07M derived: sum of 3 quarters · filed 2021-05-14 | -$21.72M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | -$17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$19.21M derived: sum of 2 quarters · filed 2021-03-26 | -$20.86M derived: sum of 3 quarters · filed 2021-03-26 | -$20.44M 10-K · filed 2021-03-26 | -$20.96M 10-K · filed 2020-03-30 | ||
| 2019-09-30 | -$1.61M 10-Q · filed 2020-11-13 | -$3.26M derived: sum of 2 quarters · filed 2020-11-13 | -$2.84M 10-Q · filed 2020-11-13 | -$10.28M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | -$1.65M 10-Q · filed 2020-08-13 | -$1.23M 10-Q · filed 2020-08-13 | -$8.67M derived: sum of 3 quarters · filed 2020-08-13 | -$12.06M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $418.13K 10-Q · filed 2020-05-14 | -$7.02M derived: sum of 2 quarters · filed 2020-05-14 | -$10.41M derived: sum of 3 quarters · filed 2020-05-14 | -$13.83M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$10.83M derived: sum of 2 quarters · filed 2020-03-30 | -$14.25M derived: sum of 3 quarters · filed 2020-03-30 | -$12.87M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$3.39M 10-Q · filed 2019-11-14 | -$6.82M derived: sum of 2 quarters · filed 2019-11-14 | -$5.44M 10-Q · filed 2019-11-14 | -$19.40M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$3.43M 10-Q · filed 2019-08-14 | -$2.05M 10-Q · filed 2019-08-14 | -$16.01M derived: sum of 3 quarters · filed 2019-08-14 | -$16.12M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $1.38M 10-Q · filed 2019-05-14 | -$12.58M derived: sum of 2 quarters · filed 2019-05-14 | -$12.69M derived: sum of 3 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$14.07M derived: sum of 2 quarters · filed 2019-03-28 | -$15.84M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$112.03K 10-Q · filed 2018-11-14 | -$1.88M 10-Q · filed 2018-11-14 | |||||
| 2013-06-30 | -$2.24M 10-Q · filed 2013-08-14 | -$4.24M 10-Q · filed 2013-08-14 | -$5.06M derived: sum of 3 quarters · filed 2013-08-14 | -$3.88M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2013-03-31 | -$1.99M 10-Q · filed 2013-05-14 | -$2.81M derived: sum of 2 quarters · filed 2013-05-14 | -$1.64M derived: sum of 3 quarters · filed 2013-05-14 | $226.28K derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-12-31 | -$818.27K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $352.59K derived: sum of 2 quarters · filed 2013-03-14 | $2.22M derived: sum of 3 quarters · filed 2013-08-14 | $5.89M 10-K · filed 2013-03-14 | |||
| 2012-09-30 | $1.17M 10-Q · filed 2012-11-14 | $3.04M derived: sum of 2 quarters · filed 2013-08-14 | $6.71M 10-Q · filed 2012-11-14 | $10.23M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-06-30 | $1.87M 10-Q · filed 2013-08-14 | $5.54M 10-Q · filed 2013-08-14 | $9.06M derived: sum of 3 quarters · filed 2013-08-14 | $15.59M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | $2.40M 10-Q · filed 2013-05-14 | $3.67M 10-Q · filed 2012-05-14 | $7.20M derived: sum of 2 quarters · filed 2013-05-14 | $13.73M derived: sum of 3 quarters · filed 2013-05-14 | $20.51M derived: sum of 4 quarters · filed 2013-05-14 | ||
| 2011-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $11.33M derived: sum of 2 quarters · filed 2013-03-14 | $18.11M derived: sum of 3 quarters · filed 2013-03-14 | $24.35M 10-K · filed 2013-03-14 | |||
| 2011-09-30 | $6.53M 10-Q · filed 2012-11-14 | $4.82M 10-Q · filed 2011-11-10 | $13.31M derived: sum of 2 quarters · filed 2012-11-14 | $19.55M 10-Q · filed 2012-11-14 | $17.84M 10-Q · filed 2011-11-10 | $27.65M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $6.78M 10-Q · filed 2012-08-14 | $13.02M 10-Q · filed 2012-08-14 | $21.11M derived: sum of 3 quarters · filed 2012-08-14 | $28.80M derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | $6.24M 10-Q · filed 2012-05-14 | $14.33M derived: sum of 2 quarters · filed 2012-05-14 | $22.02M derived: sum of 3 quarters · filed 2012-05-14 | $28.51M derived: sum of 4 quarters · filed 2012-05-14 | |||
| 2010-12-31 | $8.09M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $15.78M derived: sum of 2 quarters · filed 2012-03-14 | $22.27M derived: sum of 3 quarters · filed 2012-03-14 | $27.14M 10-K · filed 2012-03-14 | |||
| 2010-09-30 | $7.69M 10-Q/A · filed 2012-03-06 | $14.18M derived: sum of 2 quarters · filed 2012-03-06 | $19.04M 10-Q/A · filed 2012-03-06 | ||||
| 2010-06-30 | $6.49M 10-Q/A · filed 2011-09-06 | $11.35M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |